What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia

Ian M Campbell, Sarah E Sheppard, T Blaine Crowley, Daniel E McGinn, Alice Bailey, Michael J McGinn, Marta Unolt, Jelle F Homans, Erin Y Chen, Harold I Salmons, J William Gaynor, Elizabeth Goldmuntz, Oksana A Jackson, Lorraine E Katz, Maria R Mascarenhas, Vincent F X Deeney, René M Castelein, Karen B Zur, Lisa Elden, Staci KallishThomas F Kolon, Sarah E Hopkins, Madeline A Chadehumbe, Michele P Lambert, Brian J Forbes, Julie S Moldenhauer, Erica M Schindewolf, Cynthia B Solot, Edward M Moss, Raquel E Gur, Kathleen E Sullivan, Beverly S Emanuel, Elaine H Zackai, Donna M McDonald-McGinn

Research output: Contribution to journalArticle

Abstract

22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by recurrent, chromosome-specific, low copy repeat (LCR)-mediated copy-number losses of chromosome 22q11. The Children's Hospital of Philadelphia has been involved in the clinical care of individuals with what is now known as 22q11.2DS since our initial report of the association with DiGeorge syndrome in 1982. We reviewed the medical records on our continuously growing longitudinal cohort of 1,421 patients with molecularly confirmed 22q11.2DS from 1992 to 2018. Most individuals are Caucasian and older than 8 years. The mean age at diagnosis was 3.9 years. The majority of patients (85%) had typical LCR22A-LCR22D deletions, and only 7% of these typical deletions were inherited from a parent harboring the deletion constitutionally. However, 6% of individuals harbored other nested deletions that would not be identified by traditional 22q11.2 FISH, thus requiring an orthogonal technology to diagnose. Major medical problems included immune dysfunction or allergies (77%), palatal abnormalities (67%), congenital heart disease (64%), gastrointestinal difficulties (65%), endocrine dysfunction (>50%), scoliosis (50%), renal anomalies (16%), and airway abnormalities. Median full-scale intelligence quotient was 76, with no significant difference between individuals with and without congenital heart disease or hypocalcemia. Characteristic dysmorphic facial features were present in most individuals, but dermatoglyphic patterns of our cohort are similar to normal controls. This is the largest longitudinal study of patients with 22q11.2DS, helping to further describe the condition and aid in diagnosis and management. Further surveillance will likely elucidate additional clinically relevant findings as they age.

Original languageEnglish
Pages (from-to)2058-2069
Number of pages12
JournalAmerican Journal of Medical Genetics, Part A
Volume176
Issue number10
DOIs
Publication statusPublished - Oct 2018
Externally publishedYes

Fingerprint

DiGeorge Syndrome
Heart Diseases
Chromosomes
Genomic Segmental Duplications
Hypocalcemia
Dermatoglyphics
Scoliosis
Intelligence
Individuality
Medical Records
Longitudinal Studies
Hypersensitivity
Technology
Kidney

Cite this

Campbell, I. M., Sheppard, S. E., Crowley, T. B., McGinn, D. E., Bailey, A., McGinn, M. J., ... McDonald-McGinn, D. M. (2018). What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. American Journal of Medical Genetics, Part A, 176(10), 2058-2069. https://doi.org/10.1002/ajmg.a.40637

What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. / Campbell, Ian M; Sheppard, Sarah E; Crowley, T Blaine; McGinn, Daniel E; Bailey, Alice; McGinn, Michael J; Unolt, Marta; Homans, Jelle F; Chen, Erin Y; Salmons, Harold I; Gaynor, J William; Goldmuntz, Elizabeth; Jackson, Oksana A; Katz, Lorraine E; Mascarenhas, Maria R; Deeney, Vincent F X; Castelein, René M; Zur, Karen B; Elden, Lisa; Kallish, Staci; Kolon, Thomas F; Hopkins, Sarah E; Chadehumbe, Madeline A; Lambert, Michele P; Forbes, Brian J; Moldenhauer, Julie S; Schindewolf, Erica M; Solot, Cynthia B; Moss, Edward M; Gur, Raquel E; Sullivan, Kathleen E; Emanuel, Beverly S; Zackai, Elaine H; McDonald-McGinn, Donna M.

In: American Journal of Medical Genetics, Part A, Vol. 176, No. 10, 10.2018, p. 2058-2069.

Research output: Contribution to journalArticle

Campbell, IM, Sheppard, SE, Crowley, TB, McGinn, DE, Bailey, A, McGinn, MJ, Unolt, M, Homans, JF, Chen, EY, Salmons, HI, Gaynor, JW, Goldmuntz, E, Jackson, OA, Katz, LE, Mascarenhas, MR, Deeney, VFX, Castelein, RM, Zur, KB, Elden, L, Kallish, S, Kolon, TF, Hopkins, SE, Chadehumbe, MA, Lambert, MP, Forbes, BJ, Moldenhauer, JS, Schindewolf, EM, Solot, CB, Moss, EM, Gur, RE, Sullivan, KE, Emanuel, BS, Zackai, EH & McDonald-McGinn, DM 2018, 'What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia', American Journal of Medical Genetics, Part A, vol. 176, no. 10, pp. 2058-2069. https://doi.org/10.1002/ajmg.a.40637
Campbell, Ian M ; Sheppard, Sarah E ; Crowley, T Blaine ; McGinn, Daniel E ; Bailey, Alice ; McGinn, Michael J ; Unolt, Marta ; Homans, Jelle F ; Chen, Erin Y ; Salmons, Harold I ; Gaynor, J William ; Goldmuntz, Elizabeth ; Jackson, Oksana A ; Katz, Lorraine E ; Mascarenhas, Maria R ; Deeney, Vincent F X ; Castelein, René M ; Zur, Karen B ; Elden, Lisa ; Kallish, Staci ; Kolon, Thomas F ; Hopkins, Sarah E ; Chadehumbe, Madeline A ; Lambert, Michele P ; Forbes, Brian J ; Moldenhauer, Julie S ; Schindewolf, Erica M ; Solot, Cynthia B ; Moss, Edward M ; Gur, Raquel E ; Sullivan, Kathleen E ; Emanuel, Beverly S ; Zackai, Elaine H ; McDonald-McGinn, Donna M. / What is new with 22q? An update from the 22q and You Center at the Children's Hospital of Philadelphia. In: American Journal of Medical Genetics, Part A. 2018 ; Vol. 176, No. 10. pp. 2058-2069.
@article{5f6cc20934f542de983de2fe28b0f07f,
title = "What is new with 22q?: An update from the 22q and You Center at the Children's Hospital of Philadelphia",
abstract = "22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by recurrent, chromosome-specific, low copy repeat (LCR)-mediated copy-number losses of chromosome 22q11. The Children's Hospital of Philadelphia has been involved in the clinical care of individuals with what is now known as 22q11.2DS since our initial report of the association with DiGeorge syndrome in 1982. We reviewed the medical records on our continuously growing longitudinal cohort of 1,421 patients with molecularly confirmed 22q11.2DS from 1992 to 2018. Most individuals are Caucasian and older than 8 years. The mean age at diagnosis was 3.9 years. The majority of patients (85{\%}) had typical LCR22A-LCR22D deletions, and only 7{\%} of these typical deletions were inherited from a parent harboring the deletion constitutionally. However, 6{\%} of individuals harbored other nested deletions that would not be identified by traditional 22q11.2 FISH, thus requiring an orthogonal technology to diagnose. Major medical problems included immune dysfunction or allergies (77{\%}), palatal abnormalities (67{\%}), congenital heart disease (64{\%}), gastrointestinal difficulties (65{\%}), endocrine dysfunction (>50{\%}), scoliosis (50{\%}), renal anomalies (16{\%}), and airway abnormalities. Median full-scale intelligence quotient was 76, with no significant difference between individuals with and without congenital heart disease or hypocalcemia. Characteristic dysmorphic facial features were present in most individuals, but dermatoglyphic patterns of our cohort are similar to normal controls. This is the largest longitudinal study of patients with 22q11.2DS, helping to further describe the condition and aid in diagnosis and management. Further surveillance will likely elucidate additional clinically relevant findings as they age.",
author = "Campbell, {Ian M} and Sheppard, {Sarah E} and Crowley, {T Blaine} and McGinn, {Daniel E} and Alice Bailey and McGinn, {Michael J} and Marta Unolt and Homans, {Jelle F} and Chen, {Erin Y} and Salmons, {Harold I} and Gaynor, {J William} and Elizabeth Goldmuntz and Jackson, {Oksana A} and Katz, {Lorraine E} and Mascarenhas, {Maria R} and Deeney, {Vincent F X} and Castelein, {Ren{\'e} M} and Zur, {Karen B} and Lisa Elden and Staci Kallish and Kolon, {Thomas F} and Hopkins, {Sarah E} and Chadehumbe, {Madeline A} and Lambert, {Michele P} and Forbes, {Brian J} and Moldenhauer, {Julie S} and Schindewolf, {Erica M} and Solot, {Cynthia B} and Moss, {Edward M} and Gur, {Raquel E} and Sullivan, {Kathleen E} and Emanuel, {Beverly S} and Zackai, {Elaine H} and McDonald-McGinn, {Donna M}",
note = "{\circledC} 2018 Wiley Periodicals, Inc.",
year = "2018",
month = "10",
doi = "10.1002/ajmg.a.40637",
language = "English",
volume = "176",
pages = "2058--2069",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - What is new with 22q?

T2 - An update from the 22q and You Center at the Children's Hospital of Philadelphia

AU - Campbell, Ian M

AU - Sheppard, Sarah E

AU - Crowley, T Blaine

AU - McGinn, Daniel E

AU - Bailey, Alice

AU - McGinn, Michael J

AU - Unolt, Marta

AU - Homans, Jelle F

AU - Chen, Erin Y

AU - Salmons, Harold I

AU - Gaynor, J William

AU - Goldmuntz, Elizabeth

AU - Jackson, Oksana A

AU - Katz, Lorraine E

AU - Mascarenhas, Maria R

AU - Deeney, Vincent F X

AU - Castelein, René M

AU - Zur, Karen B

AU - Elden, Lisa

AU - Kallish, Staci

AU - Kolon, Thomas F

AU - Hopkins, Sarah E

AU - Chadehumbe, Madeline A

AU - Lambert, Michele P

AU - Forbes, Brian J

AU - Moldenhauer, Julie S

AU - Schindewolf, Erica M

AU - Solot, Cynthia B

AU - Moss, Edward M

AU - Gur, Raquel E

AU - Sullivan, Kathleen E

AU - Emanuel, Beverly S

AU - Zackai, Elaine H

AU - McDonald-McGinn, Donna M

N1 - © 2018 Wiley Periodicals, Inc.

PY - 2018/10

Y1 - 2018/10

N2 - 22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by recurrent, chromosome-specific, low copy repeat (LCR)-mediated copy-number losses of chromosome 22q11. The Children's Hospital of Philadelphia has been involved in the clinical care of individuals with what is now known as 22q11.2DS since our initial report of the association with DiGeorge syndrome in 1982. We reviewed the medical records on our continuously growing longitudinal cohort of 1,421 patients with molecularly confirmed 22q11.2DS from 1992 to 2018. Most individuals are Caucasian and older than 8 years. The mean age at diagnosis was 3.9 years. The majority of patients (85%) had typical LCR22A-LCR22D deletions, and only 7% of these typical deletions were inherited from a parent harboring the deletion constitutionally. However, 6% of individuals harbored other nested deletions that would not be identified by traditional 22q11.2 FISH, thus requiring an orthogonal technology to diagnose. Major medical problems included immune dysfunction or allergies (77%), palatal abnormalities (67%), congenital heart disease (64%), gastrointestinal difficulties (65%), endocrine dysfunction (>50%), scoliosis (50%), renal anomalies (16%), and airway abnormalities. Median full-scale intelligence quotient was 76, with no significant difference between individuals with and without congenital heart disease or hypocalcemia. Characteristic dysmorphic facial features were present in most individuals, but dermatoglyphic patterns of our cohort are similar to normal controls. This is the largest longitudinal study of patients with 22q11.2DS, helping to further describe the condition and aid in diagnosis and management. Further surveillance will likely elucidate additional clinically relevant findings as they age.

AB - 22q11.2 deletion syndrome (22q11.2DS) is a disorder caused by recurrent, chromosome-specific, low copy repeat (LCR)-mediated copy-number losses of chromosome 22q11. The Children's Hospital of Philadelphia has been involved in the clinical care of individuals with what is now known as 22q11.2DS since our initial report of the association with DiGeorge syndrome in 1982. We reviewed the medical records on our continuously growing longitudinal cohort of 1,421 patients with molecularly confirmed 22q11.2DS from 1992 to 2018. Most individuals are Caucasian and older than 8 years. The mean age at diagnosis was 3.9 years. The majority of patients (85%) had typical LCR22A-LCR22D deletions, and only 7% of these typical deletions were inherited from a parent harboring the deletion constitutionally. However, 6% of individuals harbored other nested deletions that would not be identified by traditional 22q11.2 FISH, thus requiring an orthogonal technology to diagnose. Major medical problems included immune dysfunction or allergies (77%), palatal abnormalities (67%), congenital heart disease (64%), gastrointestinal difficulties (65%), endocrine dysfunction (>50%), scoliosis (50%), renal anomalies (16%), and airway abnormalities. Median full-scale intelligence quotient was 76, with no significant difference between individuals with and without congenital heart disease or hypocalcemia. Characteristic dysmorphic facial features were present in most individuals, but dermatoglyphic patterns of our cohort are similar to normal controls. This is the largest longitudinal study of patients with 22q11.2DS, helping to further describe the condition and aid in diagnosis and management. Further surveillance will likely elucidate additional clinically relevant findings as they age.

U2 - 10.1002/ajmg.a.40637

DO - 10.1002/ajmg.a.40637

M3 - Article

C2 - 30380191

VL - 176

SP - 2058

EP - 2069

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 10

ER -